Head-to-head · Cost-Efficiency Index
Trimi Health vs REMEVi
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Trimi Health
Shoppers who can pay a full year up front, where the annual rate is genuinely among the cheapest all-50 tickets — and who will otherwise budget for the month-to-month rate.
Visit Trimi HealthREMEVi
Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1.
Visit REMEViThe verdict
REMEVi takes it, leading the Cost-Efficiency Index 80 to 78. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. Trimi Health still earns a C — Shoppers who can pay a full year up front, where the annual rate is genuinely among the cheapest all-50 tickets — and who will otherwise budget for the month-to-month rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Trimi Health | REMEVi |
|---|---|---|
| Cost-Efficiency Index | 78/100 | 80/100 |
| Semaglutide / mo | $175/mo month-to-month ($99/mo only on a 12-month prepay) | $219/mo |
| Tirzepatide / mo | $235/mo month-to-month ($125/mo only on a 12-month prepay) | $319/mo |
| Semaglutide / yr (modeled) | $2,100 | $2,628 |
| Tirzepatide / yr (modeled) | $2,820 | $3,828 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #32 | #33 |
Trimi Health
78/100Where the value is
- Publishes every term rung openly — annual, six-month, quarterly and monthly are all priced on the page rather than revealed at checkout
- Price is flat at every dose, so titrating up does not raise the bill
- Both molecules available on one account, nationwide, with no enrollment or consultation fee
The tradeoffs
- The advertised $99 and $125 rates require a full year paid up front; month-to-month costs $175 and $235, a 77% and 88% premium
- No public LegitScript certification, so pharmacy oversight is harder to independently verify
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.